Data / Drug companies / Atland Pharmaceuticals, LLC
Atland Pharmaceuticals, LLC: 9 products in the FDA NDC directory, labeler code 71993
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Atland Pharmaceuticals, LLC (labeler code 71993) lists 9 products in the FDA National Drug Code Directory, covering 5 finished drugs by generic name. By type: 9 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on September 18, 2026.
The request: Watch Atland Pharmaceuticals, LLC (FDA labeler code 71993): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 71993
- Products in commercial distribution
- 9
- Packages
- 9
- Finished drugs by generic name
- 5
- Prescription products
- 9
- Over the counter products
- 0
- Controlled substance products
- Schedule IV 1
- Flagged as original packager
- 7 of 7 products that carry the flag
- Started marketing in the last 12 months
- 3
- Earliest marketing start
- March 20, 2018
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 8 | 88.9% |
| Authorized generics (NDA) | 1 | 11.1% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 9 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Ranitidine | 2 | 6 |
| Tolmetin sodium | 2 | 5 |
| Orphenadrine citrate, aspirin and caffeine | 2 | 3 |
| Fenoprofen calcium | 2 | 6 |
| Quazepam | 1 | 1 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 5 | 55.6% |
| Capsule | 3 | 33.3% |
| Tablet, film coated | 1 | 11.1% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Nonsteroidal Anti-inflammatory Drug | 6 |
| Histamine-2 Receptor Antagonist | 2 |
| Central Nervous System Stimulant | 2 |
| Methylxanthine | 2 |
| Muscle Relaxant | 2 |
| Platelet Aggregation Inhibitor | 2 |
| Benzodiazepine | 1 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Ranitidine | 71993-315 | Tablet | Generic drugs (ANDA) | September 18, 2026 |
| Ranitidine | 71993-314 | Tablet | Generic drugs (ANDA) | September 18, 2026 |
| Fenoprofen calcium | 71993-313 | Capsule | Generic drugs (ANDA) | May 15, 2026 |
| Tolmetin Sodium | 71993-312 | Tablet, film coated | Generic drugs (ANDA) | February 25, 2025 |
| Tolmetin Sodium | 71993-309 | Capsule | Generic drugs (ANDA) | April 5, 2024 |
| Fenoprofen calcium | 71993-308 | Capsule | Generic drugs (ANDA) | March 26, 2024 |
| Orphenadrine Citrate, Aspirin and Caffeine | 71993-307 | Tablet | Generic drugs (ANDA) | March 1, 2023 |
| Orphenadrine Citrate, Aspirin and Caffeine | 71993-304 | Tablet | Generic drugs (ANDA) | March 18, 2022 |
| Quazepam | 71993-265 | Tablet | Authorized generics (NDA) | March 20, 2018 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.